Last Updated: Friday, 21 August 2009
Summary
Hard data on the cost-effectiveness or cost-benefit of
specific drug abuse prevention programs have proven to be elusive.
Only a handful of studies have been conducted over the past 20 years,
providing suggestive evidence that exposure to drug abuse prevention
programs could be justified based on data derived from costeffectiveness
and cost-benefit studies. As a result of this desperate
need for additional research to be focused on this topic, the National
Institute on Drug Abuse (NIDA) convened a group of experts in the
fields of drug abuse prevention research and economic evaluation
studies (cost-effectiveness and cost-benefit) to assess the current
scientific knowledge base of the efficacy of drug abuse prevention
programs, to explore state-of-the-art economic evacuation
methodologies and their application in the future to analysis of the
cost-effectiveness and cost-benefit of drug abuse prevention, and to
identify possible research directions for these types of studies that are
needed by the field of drug abuse prevention. Scientific papers from
this meeting were then reviewed, revised, and assembled to form this
publication.
This NIDA monograph attempts to place in perspective a number of
salient scientific and practical issues by providing a timely and relevant review of scientific evidence that supports drug abuse
prevention programs and policy, by discussing methodological and
analytic developments in conducting cost-benefit and costeffectiveness
studies in the area of drug abuse prevention, and by
assessing the implications of these research studies for the
development in the future of evidence-based drug abuse prevention
that would meet the highest scientific standards of excellence. This
research could lead to high-quality, accessible, effective, and costefficient
drug abuse prevention services offered in a variety of venues
to include schools, communities, the workplace, and the healthcare
system.
This monograph is based on the papers from a technical review on
“Cost-Benefit/Cost-Effectiveness Research of Drug Abuse
Prevention: Implications for Programming and Policy” held on July
28-29, 1994. The review meeting was sponsored by the National
Institute on Drug Abuse. It was edited by William J. Bukoski and Richard I. Evans. It was published as NIDA Research Monograph 176 by the National Institutes of Health of the Department of Health and Human Services in 1998.
This publication contains the following:
The Impact of Substance Abuse on Federal Spending by Jeffrey Merrill and Kimberley Fox
A Historical Perspective on Effective Prevention by Richard I. Evans
School-Based Approaches to Drug Abuse Prevention: Evidence
for Effectiveness and Suggestions for Determining
Cost-Effectiveness by Gilbert J. Botvin, Elizabeth M. Botvin, and Hirsch Ruchlin
Effectiveness of Prevention Interventions With Youth
at High Risk of Drug Abuse by Richard F. Catalano, Kevin P. Haggerty, Randy R. Gainey,
Marilyn J. Hoppe, and Devon D. Brewer
Costs, Benefits, and Cost-Effectiveness of Comprehensive Drug
Abuse Prevention by Mary Ann Pentz
Overview of Methods: Cost-Effectiveness, Cost-Benefits,
and Cost-Offsets of Prevention by Albert Woodward
Analytic Issues for Estimating the Benefits and Costs of Substance
Abuse Prevention by Gary A. Zarkin and Robert L. Hubbard
Benefits and Costs of a Family-Focused Methadone Treatment
and Drug Abuse Prevention Program: Preliminary Findings by Robert D. Plotnick, Diane S. Young, Richard F. Catalano,
and Kevin P. Haggerty
Issues and Methods in Evaluating Costs, Benefits, and
Cost-Effectiveness of Drug Abuse Prevention Programs
for High-Risk Youth by Marsha Lillie-Blanton, Lisa Werthamer, Pinka Chatterji,
Claire Fienson, and Christine Caffray
Implications for Prevention Policy: A Commentary by Robert L. DuPont
Downloads
Monograph1761.pdf
Tags
